相关实验视频
Updated: May 28, 2025

08:53
Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting
Published on: March 28, 2025
305
肝素和肝素类修饰在血液透析膜:当前的创新和未来的方向
Putu Teta Prihartini Aryanti1, Febrianto Adi Nugroho1, Yudith Yunia Kusmala2
1Chemical Engineering Dept., Faculty of Engineering, Universitas Jenderal Achmad Yani, Jl. Terusan Jenderal Achmad Yani, Cibeber, Cimahi 40531, Indonesia.
Biotechnology advances
|February 8, 2025
概括
肝素化血液透析膜通过减少凝血来增强生物相容性. 氨酸固定和纳米技术方面的创新显示出希望,但稳定性和生产方面的挑战仍然面临广泛使用.
科学领域:
- 生物材料科学 生物材料科学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 化学工程是化学工程的重要组成部分.
背景情况:
- 血液透析膜需要提高生物相容性和抗凝固特性.
- 氨酸的结合旨在减少不良的血液膜相互作用,如蛋白质吸附和凝块形成.
研究的目的:
- 审查当前的挑战和创新在肝素化血液透析膜.
- 探索氨酸固定和表面修饰技术的方法.
主要方法:
- 对氨酸固定化技术 (共价结合,层次结合,混合) 的文献综述.
- 对表面激活方法 (等离子体处理,聚合物接种) 和纳米技术集成的分析.
- 讨论包括稳定性,可扩展性和成本效益在内的挑战.
主要成果:
- 肝素固定方法通过减少蛋白质吸附和血小板粘附来提高膜性能.
- 表面激活和纳米技术增强了肝素的附着,血液兼容性和受控释放.
- 主要挑战仍然存在,包括肝素降解,涂层均性和可扩展的生产.
结论:
- 肝素化血液透析膜为更安全,更有效的透析提供了显著的潜力.
- 需要进一步的研究来解决稳定性,耐用性和成本效益的制造.
- 跨学科的方法,包括生物灵感材料和纳米技术,对于下一代膜至关重要.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
601
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
601
Dialysis
576
Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
576
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.1K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.1K

